Association of PIP5K2A with schizophrenia: A study in an indonesian family sample

PIP5K2A variants have been shown to be associated with schizophrenia in Caucasian populations. This study tested 12 PIP5K2A SNPs for association with schizophrenia in a sample of 152 sib‐pair families of Indonesian descent. All SNPs had previously been tested for association with schizophrenia in a German family sample by Schwab et al. [2006; Mol Psychiatry] and seven SNPs were nominally associated with schizophrenia in this previous study. The purpose of the study was to examine whether previously implicated PIP5K2A variants influence susceptibility to schizophrenia in populations of non‐European descent. No single markers showed nominal association with schizophrenia in this Indonesian family sample, however multi‐marker haplotypes including a previously associated exonic SNP marker revealed nominally significant association (P = 0.03). Power to detect association was greater than 80% for all previously implicated variants except for rs11013052, where power was greatly reduced due to the low minor allele frequency of this marker in the Indonesian sample. An explorative study combining the results of this study with those of our previous study indicated that rs11013052 was significantly associated with schizophrenia in the combined sample (P = 0.002). The results of this study suggest that any contribution of previously implicated DNA variants within the PIP5K2A gene to schizophrenia susceptibility in the Indonesian population is only minor. © 2008 Wiley‐Liss, Inc.

[1]  W. Maier,et al.  Evaluation of association of SNPs in the TNF alpha gene region with schizophrenia , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[2]  R. Sinke,et al.  The PIP5K2A and RGS4 genes are differentially associated with deficit and non‐deficit schizophrenia , 2007, Genes, brain, and behavior.

[3]  S. Cichon,et al.  Association study between genetic variants at the PIP5K2A gene locus and schizophrenia and bipolar affective disorder , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  W. Maier,et al.  Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIα gene (PIP5K2A) with schizophrenia , 2006, Molecular Psychiatry.

[5]  M. Munafo,et al.  Association of the NRG1 gene and schizophrenia: a meta-analysis , 2006, Molecular Psychiatry.

[6]  H. Lachman,et al.  Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia , 2005, Psychiatric genetics.

[7]  D. Nyholt,et al.  The importance of modelling heterogeneity in complex disease: application to NIMH Schizophrenia Genetics Initiative data , 2005, Human Genetics.

[8]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[9]  R. Belmaker,et al.  Valproate decreases inositol biosynthesis , 2004, Biological Psychiatry.

[10]  Michael Knapp,et al.  A powerful strategy to account for multiple testing in the context of haplotype analysis. , 2004, American journal of human genetics.

[11]  Michael Knapp,et al.  Maximum‐likelihood estimation of haplotype frequencies in nuclear families , 2004, Genetic epidemiology.

[12]  H. Lachman,et al.  Polymorphism Screening of PIP5K2A: A Candidate Gene for Chromosome 10p‐Linked Psychiatric Disorders , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[13]  T. Becker,et al.  Family-Based Association Analysis with Tightly Linked Markers , 2003, Human Heredity.

[14]  E. Lander,et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.

[15]  Hua Tang,et al.  Categorization of humans in biomedical research: genes, race and disease , 2002, Genome Biology.

[16]  John Stewart,et al.  A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. , 2002, The American journal of psychiatry.

[17]  K. Kidd,et al.  Transmission/disequilibrium tests using multiple tightly linked markers. , 2000, American journal of human genetics.

[18]  P. Holmans,et al.  Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. , 2000, American journal of human genetics.

[19]  D Castle,et al.  Psychotic Disorders in Urban Areas: An Overview of the Study on Low Prevalence Disorders , 2000, The Australian and New Zealand journal of psychiatry.

[20]  John P. Rice,et al.  Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. , 2000, American journal of medical genetics.

[21]  M. Wolfson,et al.  Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations , 2000, Brain Research.

[22]  K. Kanyas,et al.  Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. , 1998, American journal of medical genetics.

[23]  T. Matise,et al.  Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. , 1998, American journal of medical genetics.

[24]  R. Straub,et al.  A schizophrenia locus may be located in region 10p15-p11. , 1998, American journal of medical genetics.

[25]  L. Cantley,et al.  A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate , 1997, Nature.

[26]  F. McMahon,et al.  Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10, and 12. , 1997, American journal of medical genetics.

[27]  W. Sherman,et al.  The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. , 1980, The Journal of biological chemistry.

[28]  D. Comas,et al.  Extreme population differences across Neuregulin 1 gene, with implications for association studies , 2006, Molecular Psychiatry.

[29]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[30]  N. Risch,et al.  Genetic linkage and complex diseases, with special reference to psychiatric disorders , 1990, Genetic epidemiology.